During the aging process, we are all forced to deal with the natural degeneration of our bodies. However, we each experience different levels of degeneration and choose to fight our personal deterioration in a multitude of ways. One successful way to combat age-related changes in the body is non-surgical orthobiologic therapies.
There are un-programmed cells in the human body that can develop into more than one cell type. They are also at the center of a new field of science called regenerative medicine. Because these cells can become bone, muscle, cartilage and other specialized types of cells, they have the potential to treat many diseases including Parkinson’s, Alzheimer’s, Diabetes and more. Interventional orthobiologic treatments have been investigated for the treatment of many musculoskeletal disorders including osteoarthritis and osteoporosis and the investigations have turned up positive results.
BMAC cell therapy is a minimally invasive, non-surgical procedure proven to improve musculoskeletal injuries and age related degenerative conditions. The procedures utilize the patient’s own cells—harvested from fat or bone marrow—to assist the healing process of damaged tissues, tendons, ligaments, cartilage and spinal discs. The treatment offers a promising alternative for those considering elective surgery or joint replacement due to injury or arthritis. Medical researchers believe regenerative treatments have the potential to change the face of human aging and alleviate suffering.
The capacity for cells to self-renew and give rise to ensuing generations offers potential for groups of tissues that can potentially replace diseased and damaged areas in the body, with minimal risk of rejection and side effects.
Bone Marrow Concentrate (BMAC) Therapy
It is well established that a significant amount of our bodies’ cells are held within bone marrow. By harvesting blood and tissue from the bone marrow space of the hip, an injectable product can be produced by concentrating platelets and cells withdrawn through a simple outpatient procedure. This is done with local anesthetic and, occasionally, sedation. BMAC contains all of the growth and healing factors in platelet-rich plasma, along with regenerative cells, which further contribute to the regenerative process.
Cells from bone marrow are also MSCs and autologous. When age-related degeneration occurs, the usual number of regenerative cells needed for tissue renewal is often inadequate. With BMAC, the strength of the regenerative cells provides a more robust healing of the damaged tissue and aids in growth and repair by accelerating the body’s natural healing mechanism.
In studies, BMAC has been shown to reduce swelling, relieve pain, and enhance healing of articular cartilage and bone.